XNAS · ACIU
+7.20% · +$0.1901 · Vol 442.0K
Market closed · last close 4:00 PM ET · price as of 16:43:27 ET
AC Immune SA

AC Immune SA

$2.83
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
ACIU
AC Immune SA
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
STRONG

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

75/ 100
Veridion Score
STRONG · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ACIU moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ACIU catalysts
About AC Immune SA
Listed since
2016
Employees
122
Country
US

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.66
Day high
$2.94
Day low
$2.65
Previous close
$2.64
52W high
$3.99
-29.07% from high
52W low
$2.04
41% of range
Market cap
$288.3M
Beta
0.79
Shares out
99.4M
Volume
442K
2.06× rel vol
Avg volume
214.1K
VWAP
$2.86
Price history computed in-house
1W
+11.86%
1M
+26.91%
3M
-3.41%
1Y
+31.63%
YTD
-9.87%
SMA 50 $2.41 · above
SMA 200 $2.86 · below
52W position 41%

ACIU overview

Veridion Score
75
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ACIU.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ACIU Form 4 filings
Public disclosures

Congress activity in ACIU

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ACIU in the cached public ledger.

Federal contracts

ACIU contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ACIU in this window.
Lobbying spend

ACIU lobbying filings, year to date.

Registered lobbying filings matched to AC Immune SA.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ACIU in this window.
Loading news for ACIU
Analyst ratings
Sovereign unlock shows live analyst consensus for ACIU.
Options
Sovereign unlock shows live options positioning for ACIU.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.